{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:07:09Z","timestamp":1787238429633,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ajog.2023.03.039","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T11:03:07Z","timestamp":1680087787000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-8114","authenticated-orcid":false,"given":"Nicole","family":"Minalt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Yedlicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Landrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8546-1943","authenticated-orcid":false,"given":"Jeffrey F.","family":"Peipert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.03.039_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.contraception.2018.05.016","article-title":"Historical record-setting trends in IUD use in the United States","volume":"98","author":"Hubacher","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2023.03.039_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jhmas\/jrab004","article-title":"The comeback of the IUD in twenty-first century USA","volume":"76","author":"Watkins","year":"2021","journal-title":"J\u00a0Hist Med Allied Sci"},{"key":"10.1016\/j.ajog.2023.03.039_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008-2011","volume":"374","author":"Finer","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"388","key":"10.1016\/j.ajog.2023.03.039_bib4","first-page":"1","article-title":"Current contraceptive status among women aged 15-49: United States, 2017-2019","author":"Daniels","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajog.2023.03.039_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/jwh.2015.5191","article-title":"Preventing unintended pregnancy: the contraceptive CHOICE project in Review","volume":"24","author":"Birgisson","year":"2015","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2023.03.039_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humupd\/dmv023","article-title":"Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods","volume":"21","author":"Bahamondes","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2023.03.039_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.6004\/jnccn.2021.0038","article-title":"NCCN Guidelines\u00ae Insights: Uterine Neoplasms, Version 3.2021","volume":"19","author":"Abu-Rustum","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ajog.2023.03.039_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.annepidem.2010.10.002","article-title":"Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer","volume":"21","author":"Ness","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2023.03.039_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/AOG.0000000000003463","article-title":"Intrauterine device use and ovarian cancer risk: a systematic review and meta-analysis","volume":"134","author":"Wheeler","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib12","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2023.03.039_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00404-021-06380-5","article-title":"Endometrial hyperplasia as a risk factor of endometrial cancer","volume":"306","author":"Nees","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2023.03.039_bib14","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2023.03.039_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.23736\/S0026-4806.20.07072-X","article-title":"Fertility-sparing management for endometrial cancer: review of the literature","volume":"112","author":"Garzon","year":"2021","journal-title":"Minerva Med"},{"key":"10.1016\/j.ajog.2023.03.039_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ijc.2910540607","article-title":"Intra-uterine contraception and the risk of endometrial cancer","volume":"54","author":"Castellsagu\u00e9","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib18","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1002\/ijc.29229","article-title":"Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium","volume":"136","author":"Felix","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/bjc.1994.369","article-title":"Intrauterine device use and risk of endometrial cancer","volume":"70","author":"Parazzini","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0010-7824(96)00199-0","article-title":"Intrauterine devices and endometrial cancer. The WHO collaborative study of neoplasia and steroid contraceptives","volume":"54","author":"Rosenblatt","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2023.03.039_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<278::AID-IJC5>3.0.CO;2-U","article-title":"Endometrial cancer in relation to intra-uterine device use","volume":"70","author":"Hill","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/26.3.496","article-title":"Intrauterine device use and endometrial cancer risk","volume":"26","author":"Sturgeon","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2023.03.039_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0301-2115(02)00153-7","article-title":"IUD use and the risk of endometrial cancer","volume":"105","author":"Benshushan","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.03.039_bib24","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/ijc.22081","article-title":"Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China","volume":"119","author":"Tao","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib25","first-page":"949","article-title":"Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women","volume":"17","author":"Wernli","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajog.2023.03.039_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","article-title":"Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC study","volume":"149","author":"Jareid","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.03.039_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib28","first-page":"215","article-title":"Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer","volume":"14","author":"Carlson","year":"2012","journal-title":"Discov Med"},{"issue":"Suppl3","key":"10.1016\/j.ajog.2023.03.039_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/humrep\/15.suppl_3.173","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery","volume":"15","author":"Rutanen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2023.03.039_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor","volume":"22","author":"Yang","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajog.2023.03.039_bib31","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.3802\/jgo.2019.30.e57","article-title":"Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study","volume":"30","author":"Leone Roberti Maggiore","year":"2019","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.03.039_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1940-6207.CAPR-20-0248","article-title":"Progesterone therapy for endometrial cancer prevention in obese women (PROTEC) trial: a feasibility study","volume":"14","author":"Derbyshire","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.ajog.2023.03.039_bib33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2023.03.039_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2007.11.011","article-title":"Meta-analysis of intrauterine device use and risk of endometrial cancer","volume":"18","author":"Beining","year":"2008","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2023.03.039_bib35","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2023.03.039_bib36","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","article-title":"Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics","volume":"318","author":"Quinn","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.03.039_bib37","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.03.039_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.ajog.2023.03.039_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","article-title":"Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies","volume":"12","author":"Castellsagu\u00e9","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2023.03.039_bib40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","article-title":"Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib41","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/humrep\/deab066","article-title":"Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark","volume":"36","author":"Skorstengaard","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2023.03.039_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/AOG.0000000000003656","article-title":"Relative risk of cervical neoplasms among copper and levonorgestrel-releasing intrauterine system users","volume":"135","author":"Spotnitz","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib43","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.03.039_bib44","first-page":"550","article-title":"Long-term cytologic studies of copper-IUD users","volume":"25","author":"Engineer","year":"1981","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ajog.2023.03.039_bib45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0026-0495(65)90022-3","article-title":"Studies on vaginal, cervical and uterine histology","volume":"14","author":"Pincus","year":"1965","journal-title":"Metabolism"},{"key":"10.1016\/j.ajog.2023.03.039_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2019.10.009","article-title":"Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study","volume":"124","author":"Loopik","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib47","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/AOG.0000000000000760","article-title":"Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices","volume":"125","author":"Lekovich","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2006.10.014","article-title":"Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix","volume":"264","author":"Delvenne","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajog.2023.03.039_bib49","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ajog.2023.03.039_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/er.2017-00103","article-title":"Hormonal contraception and HIV-1 acquisition: biological mechanisms","volume":"39","author":"Hapgood","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2023.03.039_bib51","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.03.039_bib52","first-page":"183","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2023.03.039_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001648-200105000-00010","article-title":"Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer","volume":"12","author":"Ness","year":"2001","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2023.03.039_bib54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/01443615.2020.1789960","article-title":"Ever-use of the intra-uterine device and the risk of ovarian cancer","volume":"41","author":"Balayla","year":"2021","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.03.039_bib55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ijc.29412","article-title":"Contraceptive methods and ovarian cancer risk among Chinese women: a report from the Shanghai Women\u2019s Health Study","volume":"137","author":"Huang","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib56","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2023.03.039_bib57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijgo.13737","article-title":"Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer","volume":"156","author":"D\u2019Alessandro","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2023.03.039_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.33531","article-title":"Intrauterine device use and risk of ovarian cancer: results from the New England Case-Control study and Nurses\u2019 Health Studies","volume":"149","author":"Yang","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.03.039_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.annepidem.2021.04.006","article-title":"Association of partner vasectomy, depot medroxyprogesterone acetate and intrauterine contraceptive devices with ovarian cancer","volume":"60","author":"Chesang","year":"2021","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2023.03.039_bib60","first-page":"187","article-title":"Vaginal pH effects caused by OCs and various copper and inert IUDs","volume":"4","author":"Kandil","year":"1983","journal-title":"Contracept Deliv Syst"},{"key":"10.1016\/j.ajog.2023.03.039_bib61","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/s41598-017-08805-1","article-title":"Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823002247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823002247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:42:16Z","timestamp":1757590936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823002247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0002937823002247"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.03.039","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}